asperflavin has been researched along with ofloxacin in 1 studies
Studies (asperflavin) | Trials (asperflavin) | Recent Studies (post-2010) (asperflavin) | Studies (ofloxacin) | Trials (ofloxacin) | Recent Studies (post-2010) (ofloxacin) |
---|---|---|---|---|---|
5 | 0 | 2 | 6,484 | 976 | 1,346 |
Protein | Taxonomy | asperflavin (IC50) | ofloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit A | Escherichia coli K-12 | 1.5 | |
DNA gyrase subunit B | Escherichia coli K-12 | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S | 1 |
1 other study(ies) available for asperflavin and ofloxacin
Article | Year |
---|---|
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship | 2015 |